Organicell Announces Matt Sinnreich as CEO
07/26/2022
07:31
“ MIAMI, FL / ACCESSWIRE / July 26, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company principally focusing on the development of
None
>
>
OTC:
OCEL
OCEL
- Sector: None
Recent publications about $OCEL
Organicell Announces Matt Sinnreich as CEO
07/26/2022
07:30
MIAMI, FL / ACCESSWIRE / July 26, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company principally focusing on the development of innovative
Organicell Regenerative Medicine, Inc. Secures $4 Million in Funding for Clinical Trials and Agrees To Restructure Management
07/20/2022
07:30
“ MIAMI, FL / ACCESSWIRE / July 20, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company principally focusing on the development of
Organicell Regenerative Medicine, Inc. Secures $4 Million in Funding for Clinical Trials and Agrees To Restructure Management
07/20/2022
07:30
MIAMI, FL / ACCESSWIRE / July 20, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company principally focusing on the development of innovative
Organicell And Proxima CRO Set To Open Clinical Trial For Long Hauler COVID-19 Patients
02/08/2022
07:30
MIAMI, FL / ACCESSWIRE / February 8, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies,
Organicell Regenerative Medicine, Inc. Provides Updates of Clinical Trial Activities
12/29/2021
07:30
MIAMI, FL / ACCESSWIRE / December 29, 2021 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies,
Organicell Regenerative Medicine, Inc. Uplist Of Common Stock To OTCQB Approved
11/09/2021
10:27
MIAMI, Nov. 9, 2021 /PRNewswire/ – Organicell Regenerative Medicine, Inc. (OTCQB: OCEL), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced today that
SOTD Membership
Customer Service
Privacy Notice | Terms of Use | Sitemap
Copyright © 2022 stocksoftheday.com. Stocks of the Day does not provide investment advice. All rights reserved.
Copyright © 2022 stocksoftheday.com. Stocks of the Day does not provide investment advice. All rights reserved.